Cabot Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-2,320
| Closed | -$354K | – | 169 |
|
|
2021
Q4 | $354K | Hold |
2,320
| – | – | 0.04% | 133 |
|
|
2021
Q3 | $375K | Hold |
2,320
| – | – | 0.05% | 127 |
|
|
2021
Q2 | $380K | Sell |
2,320
-79
| -3% | -$12.9K | 0.05% | 125 |
|
|
2021
Q1 | $361K | Sell |
2,399
-38
| -2% | -$5.72K | 0.05% | 124 |
|
|
2020
Q4 | $369K | Hold |
2,437
| – | – | 0.06% | 118 |
|
|
2020
Q3 | $330K | Buy |
+2,437
| New | +$330K | 0.06% | 113 |
|
|
2018
Q1 | – | Sell |
-2,103
| Closed | -$225K | – | 130 |
|
|
2017
Q4 | $225K | Sell |
2,103
-240
| -10% | -$25.7K | 0.05% | 126 |
|
|
2017
Q3 | $261K | Sell |
2,343
-63
| -3% | -$7.02K | 0.06% | 118 |
|
|
2017
Q2 | $249K | Sell |
2,406
-189
| -7% | -$19.6K | 0.06% | 121 |
|
|
2017
Q1 | $254K | Sell |
2,595
-303
| -10% | -$29.7K | 0.06% | 124 |
|
|
2016
Q4 | $256K | Sell |
2,898
-3,723
| -56% | -$329K | 0.07% | 128 |
|
|
2016
Q3 | $639K | Sell |
6,621
-675
| -9% | -$65.1K | 0.16% | 102 |
|
|
2016
Q2 | $626K | Sell |
7,296
-1,242
| -15% | -$107K | 0.16% | 101 |
|
|
2016
Q1 | $742K | Sell |
8,538
-720
| -8% | -$62.6K | 0.21% | 91 |
|
|
2015
Q4 | $1.04M | Buy |
9,258
+45
| +0.5% | +$5.08K | 0.27% | 94 |
|
|
2015
Q3 | $932K | Buy |
9,213
+777
| +9% | +$78.6K | 0.26% | 89 |
|
|
2015
Q2 | $1.04M | Sell |
8,436
-855
| -9% | -$105K | 0.25% | 93 |
|
|
2015
Q1 | $1.06M | Sell |
9,291
-69
| -0.7% | -$7.9K | 0.26% | 95 |
|
|
2014
Q4 | $946K | Sell |
9,360
-1,035
| -10% | -$105K | 0.23% | 98 |
|
|
2014
Q3 | $948K | Sell |
10,395
-1,110
| -10% | -$101K | 0.24% | 103 |
|
|
2014
Q2 | $986K | Sell |
11,505
-246
| -2% | -$21.1K | 0.25% | 98 |
|
|
2014
Q1 | $926K | Sell |
11,751
-315
| -3% | -$24.8K | 0.24% | 107 |
|
|
2013
Q4 | $913K | Sell |
12,066
-3,108
| -20% | -$235K | 0.24% | 114 |
|
|
2013
Q3 | $1.06M | Buy |
15,174
+4,986
| +49% | +$348K | 0.32% | 105 |
|
|
2013
Q2 | $590K | Buy |
+10,188
| New | +$590K | 0.2% | 133 |
|